These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 31432248)
1. Expression of fatty-acid-binding protein 5 in intrahepatic and extrahepatic cholangiocarcinoma: the possibility of different energy metabolisms in anatomical location. Nakagawa R; Hiep NC; Ouchi H; Sato Y; Harada K Med Mol Morphol; 2020 Mar; 53(1):42-49. PubMed ID: 31432248 [TBL] [Abstract][Full Text] [Related]
2. The epidemiological trends of biliary tract cancers in the United States of America. Jiang Y; Jiang L; Li F; Li Q; Yuan S; Huang S; Fu Y; Yan X; Chen J; Li H; Li S; Liu J BMC Gastroenterol; 2022 Dec; 22(1):546. PubMed ID: 36581813 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice. Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050 [TBL] [Abstract][Full Text] [Related]
4. [Gallbladder and bile duct carcinoma. Biology and pathology]. Tannapfel A; Wittekind C Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242 [TBL] [Abstract][Full Text] [Related]
5. Mutational spectrum and precision oncology for biliary tract carcinoma. Lin J; Cao Y; Yang X; Li G; Shi Y; Wang D; Long J; Song Y; Mao J; Xie F; Bai Y; Zhang L; Yang X; Wan X; Wang A; Guan M; Zhao L; Hu K; Pan J; Huo L; Lu X; Mao Y; Sang X; Zhang H; Wang K; Wang X; Zhao H Theranostics; 2021; 11(10):4585-4598. PubMed ID: 33754015 [No Abstract] [Full Text] [Related]
6. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center. Roos E; Strijker M; Franken LC; Busch OR; van Hooft JE; Klümpen HJ; van Laarhoven HW; Wilmink JW; Verheij J; van Gulik TM; Besselink MG HPB (Oxford); 2020 Mar; 22(3):405-414. PubMed ID: 31494056 [TBL] [Abstract][Full Text] [Related]
7. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734 [TBL] [Abstract][Full Text] [Related]
8. Systemic treatment of advanced or recurrent biliary tract cancer. Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166 [TBL] [Abstract][Full Text] [Related]
9. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma. Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302 [TBL] [Abstract][Full Text] [Related]
10. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah. Samadder NJ; Smith KR; Wong J; Hanson H; Boucher K; Burt RW; Charlton M; Byrne KR; Gallegos-Orozco JF; Koptiuch C; Curtin K Dig Dis Sci; 2016 Dec; 61(12):3627-3632. PubMed ID: 27655103 [TBL] [Abstract][Full Text] [Related]
11. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328 [TBL] [Abstract][Full Text] [Related]
16. Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers. Elshami M; Ammori JB; Hardacre JM; Selfridge JE; Bajor D; Mohamed A; Chakrabarti S; Mahipal A; Winter JM; Ocuin LM J Surg Res; 2024 Mar; 295():705-716. PubMed ID: 38141457 [TBL] [Abstract][Full Text] [Related]
17. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma. Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139 [TBL] [Abstract][Full Text] [Related]
18. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer. Yang Z Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):19-25. PubMed ID: 25153498 [TBL] [Abstract][Full Text] [Related]
19. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996 [TBL] [Abstract][Full Text] [Related]